Observational Health Data Sciences and Informatics (OHDSI)
This sponsor has funded 1 studies across 9 countries.
| EU PAS ID | Status | Title | Protocol uploaded | Results uploaded |
|---|---|---|---|---|
| 33253 | Ongoing | Utilisation disease-modifying anti-rheumatic drugs (DMARDs) used for the treatment of rheumatoid arthritis: protocol for a multi-database real-world... | No | No |
PAS by Risk Management Plan (RMP) requirement
Observational Health Data Sciences and Informatics (OHDSI)
The RMP for a medical product outlines strategies to identify, assess, and mitigate risks, including PAS for further evaluation.
Category 1 studies are imposed as condition of marketing authorisation.
Category 2 studies are imposed as specific obligation of marketing authorisation.
Category 3 studies are required under other circumstances.
PAS by study status
Observational Health Data Sciences and Informatics (OHDSI)
The study status is defined according to the timeline dates specified.
Planned studies have not collected any data yet.
Ongoing studies collect data and should publish protocols as soon as possible.
Finalised studies should publish results in the first two weeks after finalisation.
Countries
Observational Health Data Sciences and Informatics (OHDSI)
9 Study countries specified are the following:
- Austria
- Belgium
- Estonia
- France
- Germany
- Japan
- Spain
- United Kingdom
- United States